Wilhelm W, Wrobel M, Kreuer S, Larsen R
Klinik für Anaesthesiologie und Intensivmedizin, Universitätskliniken des Saarlandes, Homburg/Saar.
Anaesthesist. 2003 Jun;52(6):473-94. doi: 10.1007/s00101-003-0540-9.
Remifentanil is a 4-anilidopiperidine mu-opioid analgesic which is rapidly metabolized by unspecific blood and tissue esterases. According to its unique pharmacokinetic profile, remifentanil-based anaesthesia combines high-dosage opioid analgesia intraoperatively with a rapid and predictable postoperative awakening. When compared with a standard fentanyl-based technique, the use of remifentanil has changed our present anaesthetic regimens. This includes the anaesthesia induction sequence, the choice and dosage of anaesthetics when used as adjuncts to remifentanil, and even more, the proper planning of postoperative pain management. The present paper was designed to review the current knowledge on remifentanil and all aspects of its use in anaesthesiology. In addition, present data on the use of remifentanil for analgesia and sedation of the critically ill patient are summarized.
瑞芬太尼是一种4-苯胺基哌啶类μ阿片受体镇痛药,可被非特异性血液和组织酯酶迅速代谢。根据其独特的药代动力学特征,基于瑞芬太尼的麻醉在术中结合了高剂量阿片类镇痛与快速且可预测的术后苏醒。与基于芬太尼的标准技术相比,瑞芬太尼的使用改变了我们目前的麻醉方案。这包括麻醉诱导顺序、作为瑞芬太尼辅助用药时麻醉药的选择和剂量,甚至还包括术后疼痛管理的合理规划。本文旨在综述目前关于瑞芬太尼及其在麻醉学中应用各方面的知识。此外,还总结了目前关于瑞芬太尼用于危重症患者镇痛和镇静的数据。